These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1213 related articles for article (PubMed ID: 22112553)

  • 1. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.
    Mousa AY; Campbell JE; Stone PA; Broce M; Bates MC; AbuRahma AF
    J Vasc Surg; 2012 Feb; 55(2):421-7. PubMed ID: 22112553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and treatment of renal artery fibromuscular dysplasia with percutaneous transluminal angioplasty: a long-term follow-up study.
    Yang YK; Zhang Y; Meng X; Yang KQ; Jiang XJ; Wu HY; Zhang HM; Song L; Wang LP; Gao LG; Zhou XL
    Clin Res Cardiol; 2016 Nov; 105(11):930-937. PubMed ID: 27270759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year experience with renal artery in-stent stenosis.
    Stone PA; Campbell JE; Aburahma AF; Hamdan M; Broce M; Nanjundappa A; Bates MC
    J Vasc Surg; 2011 Apr; 53(4):1026-31. PubMed ID: 21215576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of long-term beneficial effects on blood pressure after percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis.
    Alhadad A; Mattiasson I; Ivancev K; Lindblad B; Gottsäter A
    Int Angiol; 2009 Apr; 28(2):106-12. PubMed ID: 19367240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial.
    Jaff MR; Bates M; Sullivan T; Popma J; Gao X; Zaugg M; Verta P;
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):343-50. PubMed ID: 22511402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endovascular management of atherosclerotic renovascular disease: early results following primary intervention.
    Corriere MA; Pearce JD; Edwards MS; Stafford JM; Hansen KJ
    J Vasc Surg; 2008 Sep; 48(3):580-7; discussion 587-8. PubMed ID: 18727962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and mid-term results of balloon angioplasty for renal artery fibromuscular dysplasia.
    Fujihara M; Fukata M; Higashimori A; Nakamura H; Odashiro K; Yokoi Y
    Cardiovasc Interv Ther; 2014 Oct; 29(4):293-9. PubMed ID: 24566834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights from intravascular pressure measurement of renal artery revascularization in patients with fibromuscular dysplasia: The DYSART study.
    Cadour F; Silhol F; Iline N; Giorgi R; Lorthioir A; Amar L; Sapoval M; Rousseau H; Sarlon G; Thony F; Jacquier A
    J Vasc Surg; 2022 Mar; 75(3):939-949.e1. PubMed ID: 34601043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal artery revascularization: outcomes stratified by indication for intervention.
    Patel VI; Conrad MF; Kwolek CJ; LaMuraglia GM; Chung TK; Cambria RP
    J Vasc Surg; 2009 Jun; 49(6):1480-9. PubMed ID: 19497511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal artery stent fracture in patients with fibromuscular dysplasia: a cautionary tale.
    Raju MG; Bajzer CT; Clair DG; Kim ES; Gornik HL
    Circ Cardiovasc Interv; 2013 Jun; 6(3):e30-1. PubMed ID: 23780296
    [No Abstract]   [Full Text] [Related]  

  • 11. Percutaneous transluminal angioplasty with selective stenting for the treatment of renal artery stenosis caused by fibromuscular dysplasia: 18 years' experience from the China Center for Cardiovascular Disease.
    Chen Y; Dong H; Jiang X; Deng Y; Zou Y; Che W; Xiong H; Xu B; Yang Y; Gao R
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():641-647. PubMed ID: 31943685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misconceptions about the diagnosis and treatment of fibromuscular dysplasia.
    Olin JW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):265-6. PubMed ID: 19642172
    [No Abstract]   [Full Text] [Related]  

  • 13. Predicting blood pressure response after renal artery stenting.
    Beck AW; Nolan BW; De Martino R; Yuo TH; Tanski WJ; Walsh DB; Powell RP; Cronenwett JL
    J Vasc Surg; 2010 Feb; 51(2):380-5; discussion 385. PubMed ID: 19939607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, multi-center, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis (RADAR) - one-year results of a pre-maturely terminated study.
    Zeller T; Krankenberg H; Erglis A; Blessing E; Fuss T; Scheinert D; Weser R; Doerr BB; Yollo WD; Radermacher J;
    Trials; 2017 Aug; 18(1):380. PubMed ID: 28807045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of renal artery fibromuscular dysplasia: angiography, intravascular ultrasound (with virtual histology), and pressure wire measurements.
    Prasad A; Zafar N; Mahmud E
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):260-4. PubMed ID: 19213069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up for percutaneous transluminal angioplasty in renal artery fibromuscular dysplasia.
    Gavalas MV; Gasparis AP; Tassiopoulos AK; Loh S; Labropoulos N
    Int Angiol; 2015 Dec; 34(6):529-37. PubMed ID: 24824840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Renovascular Hypertension.
    Smith A; Gaba RC; Bui JT; Minocha J
    Tech Vasc Interv Radiol; 2016 Sep; 19(3):211-7. PubMed ID: 27641455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Status of Renal Artery Angioplasty and Stenting for Resistant Hypertension: A Case Series and Review of the Literature.
    Manolis AS; Manolis AA; Melita H
    Curr Hypertens Rev; 2017; 13(2):93-103. PubMed ID: 28782466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD).
    Balzer KM; Pfeiffer T; Rossbach S; Voiculescu A; Mödder U; Godehardt E; Sandmann W
    J Vasc Surg; 2009 Mar; 49(3):667-74; discussion 674-5. PubMed ID: 19135837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of metabolic syndrome on the outcomes of percutaneous renal angioplasty and stenting.
    Davies MG; Saad WE; Bismuth J; Naoum JJ; Peden EK; Lumsden AB
    J Vasc Surg; 2010 Apr; 51(4):926-32. PubMed ID: 20022208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.